Technical Analysis for TLSI - TriSalus Life Sciences, Inc.

Grade Last Price % Change Price Change
D 9.43 -3.08% -0.30
TLSI closed down 3.08 percent on Friday, April 12, 2024, on 1.27 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Multiple of Ten Bearish Other 0.00%
Gapped Up Strength 0.00%
MACD Bearish Signal Line Cross Bearish -3.08%
Multiple of Ten Bearish Other -3.08%
Inside Day Range Contraction -3.08%
Gapped Up Strength -3.08%
20 DMA Support Bullish -2.78%
Multiple of Ten Bearish Other -2.78%

   Recent Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

TriSalus Life Sciences, Inc., an immunotherapy company that develops and commercializes immunotherapies for the treatment of liver and pancreatic tumors. The company offers the TriNav Infusion System for hepatic arterial infusion of liver tumors; and the Pancreatic Retrograde Venous Infusion System for pancreatic tumors. It also develops SD-101, an investigational immunotherapeutic with pressure-enabled drug delivery technology for hepatocellular carcinoma, intrahepatic cholangiocarcinoma, uveal melanoma with liver metastases, pancreatic ductal adenocarcinoma with liver metastases, colorectal cancer with liver metastases, and primary pancreatic cancers. The company is based in Westminster, Colorado.
Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Cancer Immunotherapy Immunotherapies Colorectal Cancer Pancreatic Cancer Hepatology Hepatocellular Carcinoma Uveal Melanoma Cholangiocarcinoma Intrahepatic Cholangiocarcinoma

Is TLSI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 16.24
52 Week Low 3.33
Average Volume 34,051
200-Day Moving Average 0.00
50-Day Moving Average 9.54
20-Day Moving Average 9.64
10-Day Moving Average 9.83
Average True Range 0.53
RSI (14) 46.52
ADX 24.44
+DI 22.25
-DI 12.62
Chandelier Exit (Long, 3 ATRs) 8.84
Chandelier Exit (Short, 3 ATRs) 10.38
Upper Bollinger Bands 10.23
Lower Bollinger Band 9.05
Percent B (%b) 0.32
BandWidth 12.25
MACD Line 0.08
MACD Signal Line 0.11
MACD Histogram -0.0305
Fundamentals Value
Market Cap 249.08 Million
Num Shares 26.4 Million
EPS -1.99
Price-to-Earnings (P/E) Ratio -4.74
Price-to-Sales 16.03
Price-to-Book 29.91
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.54
Resistance 3 (R3) 10.62 10.34 10.36
Resistance 2 (R2) 10.34 10.05 10.30 10.29
Resistance 1 (R1) 9.88 9.88 9.74 9.80 10.23
Pivot Point 9.60 9.60 9.53 9.56 9.60
Support 1 (S1) 9.14 9.31 9.00 9.06 8.63
Support 2 (S2) 8.86 9.14 8.82 8.57
Support 3 (S3) 8.40 8.86 8.51
Support 4 (S4) 8.32